SF
Space Forge Financial Model

Biotech/Pharma Startup Financials (Free Excel Download)

In-space manufacturing company building fully returnable and re-launchable satellite platforms (ForgeStar™) to produce materials impossible to make on Earth.

Loading...

Used by professionals from

KPMG logoWharton logoColumbia logoESSEC logoPwC logoHEC logo

About this model

Space Forge is building ForgeStar, a fully returnable and re-launchable satellite platform for manufacturing in microgravity, vacuum, and near-absolute-zero conditions. The company targets advanced semiconductors, composites, and pharmaceuticals that cannot be made terrestrially, with soft-return capability differentiating it from an ISS-based process.

The deck implies a platform-as-a-service model in which industrial customers pay per manufacturing mission or quantity of material returned to Earth. Government or agency contracts may support early revenue, but no customer, contract, mission price, volume, or launch schedule is disclosed in the research.

The team comprised 25 people from 12 countries. ForgeStar’s proposed Earth-side benefits include up to 60% lower energy use and decarbonisation in automotive applications. The model should schedule launches, mission capacity, customer contracts, spacecraft capex, launch and return cost, reliability, insurance, and R&D.

A turnkey financial model

Live formulas, no hardcoded values

Outputs are driven by live formulas, so the workbook updates from its assumptions instead of relying on hardcoded results.

All assumptions in one tab

Inputs are clearly marked in the Assumptions tab and separated from calculations, making it clear what to change and what to leave intact.

Statements always balancing

For integrated-statement models, the balance sheet, cash flow, and supporting schedules tie through properly.

Distinct schedules for clarity

Debt, working capital, taxes, and cash flow can get messy quickly. We group calculations in clear schedules, not across disconnected tabs.

No hidden macros or external links

There are no unexplained external workbook links or macros to undermine auditability or portability.

Changes flow through the model

Update a key driver and see the impact carry through the forecast, financing, and return outputs. We never use hardcoded numbers in formulas.

About Space Forge

Read the pitch deck
Space Forge pitch deck cover
View on makeslides.com
Total raised
$10.0M
Funding round
Seed
Founded
2021
Category
Biotech/Pharma
Customer
B2C
Geography
UK

How to build a detailed financial model for Space Forge

A complete walkthrough of the business, drivers, and assumptions behind the downloadable Space Forge model - distilled from its pitch deck and publicly available information.

Product & value proposition

  • Product: ForgeStar™ - world's first fully returnable and re-launchable satellite platform.
  • Enables manufacturing in microgravity, vacuum, and near-absolute-zero conditions.
  • Target output materials: advanced semiconductors, composites, pharmaceuticals.
  • Key differentiators vs. ISS: dedicated platform (not constrained by ISS schedule), scalable, and has soft-return capability.
  • Claimed Earth-side impact: up to 60% energy reduction; decarbonisation of automotive applications.

Revenue model

Not explicitly stated in deck. Implied model:

  • Platform-as-a-service / manufacturing runs: customers (pharma, semiconductor, composites firms) pay per mission or per kg of manufactured material returned to Earth. Rationale: business is positioning itself as infrastructure provider enabling customers to manufacture novel materials in orbit.
  • Potentially also government/agency contracts (UK Space Agency background of CEO suggests agency relationships). Rationale: space hardware companies at this stage typically rely on government contracts for early revenue.

Traction & metrics

Team headcount only: 25 people from 12 countries.

Competition / moat

Not explicitly a dedicated competition slide. Implied moats from problem/solution framing:

  • First-mover: positioning as world's first fully returnable and re-launchable satellite for manufacturing.
  • Technical barriers: soft-return capability; dedicated platform vs. ISS dependency.
  • No competitive landscape chart shown.

Team & funding ask / use of funds

  • Co-founders:
  • Josh Western (CEO) - UK Space Agency, Thales Alenia Space background.
  • Andrew Bacon (CTO) - Thales Alenia Space, SEA/Cohort, AAC Clyde background.
  • Team: 25 people from 12 countries; disciplines span astrophysics to materials science.

Recommended financial model

  • Archetype + why: Hardware + Manufacturing-as-a-Service (MaaS) 3-statement model with milestone-based revenue. Space Forge is pre-revenue deep-tech hardware; the model needs to capture: (a) R&D/capex burn through platform development, (b) first mission revenue tied to ForgeStar launches, (c) a recurring MaaS revenue stream per mission once operational. A standard SaaS ARR model is wrong here - revenue is mission-discrete, not subscription. A 3-statement model with a hardware production schedule and MaaS revenue layer is the right structure.
  • Forecast horizon & granularity: 7–10 years (development + early commercial ramp); monthly for years 1–2 (cash burn planning), quarterly for years 3–5, annual thereafter.
  • Key drivers & assumptions:
  • ForgeStar unit development cost - capital-intensive; rationale: satellite platforms at this scale typically cost £5–20M to develop; no deck figure.
  • Time to first launch / mission - 2–4 years from seed; rationale: typical small-sat deep-tech timeline; no deck figure.
  • Mission cadence (launches per year) - 1–2 in early years scaling to 4–6 as platform is reused; rationale: re-launchability is the core value prop, implying multi-use per unit.
  • Revenue per mission / kg returned - pricing TBD; comparable ISS experiment costs suggest $10k–$100k+ per kg; no deck figure.
  • Reuse rate per ForgeStar unit - key economic lever; no deck figure.
  • Headcount growth from 25 base; burn rate based on 25-person deep-tech team (est. £3–5M/year fully loaded).
  • Materials addressed: semiconductors, composites, pharmaceuticals - size and willingness-to-pay vary significantly by vertical; model should split by vertical.
  • Energy reduction claim (60%) - supports premium pricing narrative but not a direct financial driver.
  • Government grant / contract revenue - likely meaningful at early stage given UK Space Agency ties; no deck figure.
  • Scenarios (Base / Bull / Bear - which variables flex):
  • Bear: Launch delayed by 2 years; low mission cadence (1/year); low price per mission; minimal reuse.
  • Base: First launch in 3 years; 2–3 missions/year by year 5; moderate per-mission pricing; 3–5 reuses per unit.
  • Bull: First launch in 2 years; strong government contracts bridge; 4+ missions/year by year 5; high per-mission pricing from pharma/semiconductor premium customers.
  • Required sheets / outputs:
  1. Assumptions - all drivers, clearly tagged vs.
  2. Development timeline / milestones - ForgeStar build, test, launch schedule.
  3. Revenue - mission schedule × price per mission, split by vertical (semiconductors / composites / pharma).
  4. OpEx - R&D, headcount, launch costs (third-party launch vehicle), operations.
  5. CapEx - ForgeStar unit build costs; maintenance / refurbishment per reuse.
  6. P&L (Income Statement).
  7. Cash Flow - critical: pre-revenue burn and funding runway.
  8. Balance Sheet.
  9. KPI summary - missions per year, revenue per mission, reuse count, runway months.

Frequently asked

Is the Space Forge financial model free?+

Yes. The Space Forge model is a free Excel (.xlsx) download with live formulas. Sign up with your email and the workbook is yours to keep, review, and edit.

What's included in the model?+

A 5-year monthly forecast with P&L, cash flow and runway, valuation (exit multiple plus a DCF cross-check), MOIC/IRR returns, and unit economics, with live formulas throughout.

How was this model built?+

It was built from Space Forge's pitch deck and publicly available information, then structured to investment-banking standards as a fully editable Excel model.

Can I change the assumptions?+

Yes. You can change assumptions and the live formulas will recalculate in the downloadable Excel model.

Have more financial modelling questions? Contact us

Alex Tapio, ex-Deloitte financial modelling expert

Created by ex-finance professionals

Hey, I’m Alex and I created Finamodel.

Over my years in the finance industry I kept building the same models over and over again. Same structure, same assumptions, different logo. So I started building frameworks to turn them into clean, reusable templates.

Every model here is one I’d actually use for a client, and I personally vet each one before it goes up.

I’m not an expert in every industry, but I’ve built enough models to know what belongs in one. And when something is completely foreign to me, I reach out to my network for experts to work on our models with us.

Having a template library on hand cuts a first build from hours to minutes.

Need help finding your model? You’ll find me in the Finamodel app!

Other Biotech/Pharma Startup Financial Models

Browse another startup in the same category.

ada-health.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Ada Health logo

Ada Health

AI-powered symptom assessment app and clinical decision-support platform for consumers and healthcare partners.

affini-t.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
AF

Affini-T

Engineered T cell therapies targeting oncogenic driver mutations (KRAS, p53) in hard-to-treat solid tumors

alto-pharmacy.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Alto Pharmacy logo

Alto Pharmacy

Alto Pharmacy is a tech-enabled, same-day prescription delivery pharmacy disrupting the $450B US pharmacy market via a direct-to-patient courier model and provider-facing software platform.

apheabio.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Aphea.Bio logo

Aphea.Bio

Aphea.Bio is a Belgian ag-biotech company developing and commercialising microbial biologicals (biostimulants, biofungicides, bioherbicides, bioinsecticides) for row crops, targeting yield improvement and reduced synthetic input use.

aurion-biotech.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Aurion Biotech logo

Aurion Biotech

Cell therapy company developing an injectable corneal endothelial cell treatment to restore vision in patients with corneal endothelial disease.

beckley-psytech.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Beckley Psytech logo

Beckley Psytech

Clinical-stage psychedelic drug development platform advancing a pipeline of psychedelic compounds (psilocybin, 5-MeO-DMT, NCEs) as licensed pharmaceutical medicines for neuropsychiatric disorders.

brightinsight.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
BrightInsight logo

BrightInsight

Regulated digital health platform-as-a-service for biopharma and medtech companies to build, launch, and maintain compliant connected-drug and medical-device software products.

carrum-health.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
CH

Carrum Health

Value-based care marketplace connecting self-insured employers to top-tier surgical and oncology Centers of Excellence (COEs) via all-inclusive bundled payments.

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview